how does semaglutide reduce cardiovascular risk Shows Secondary Prevention Benefits in Patients Without Diabetes Insights into semaglutide cardiovascular research:

2025 GLP-1 research shows that GLP-1 agonists like semaglutide and tirzepatide not only help reduce weight but may also play an indirect role in improving cardiometabolic outcomes, such as blood pressure and lipid profiles

Harlan Krumholz, a cardiologist and professor at the Yale School of Medicine

How tirzepatide supports weight loss Tirzepatide offers multiple benefits that make it an effective tool for weight management: Appetite control: Reduces hunger signals to help you feel satisfied with smaller portions Improved blood sugar regulation: Tirzepatide balances blood glucose levels, which can contribute to better overall health and weight management Enhanced fat burning: Promotes metabolic changes that encourage the body to burn stored fat Sustainable results: Clinical trials have shown significant weight loss in patients that often exceed results from other medications like semaglutide

Seprish said

Third, semaglutide reduces the amount of glucagon your liver releases